TK1 and cancer: The results specifically presented here demonstrate that the monoclonal canine TK1 ELISA may serve as an efficient tool to estimate the increased cell proliferation responsible for the aggressiveness and type of canine lymphoma, which can aid cancer management in veterinary medicine.